|1.||Tarak, K C: 1 article (12/2013)|
|2.||Joshi, Hanumanthachar: 1 article (12/2013)|
|3.||Biradar, S M: 1 article (12/2013)|
|4.||Seitz, Cornelia S: 1 article (01/2008)|
|5.||Bröcker, Eva B: 1 article (01/2008)|
|6.||Trautmann, Axel: 1 article (01/2008)|
|7.||Gaigl, Zeno: 1 article (01/2008)|
|8.||Graus, F: 1 article (12/2002)|
|9.||Saiz, A: 1 article (12/2002)|
12/01/2013 - "In Elevated Plus Maze (EPM) and Passive Shock Avoidance paradigm (PSA) the TAPH shown improved acquisition and retention memory significantly (p < 0.001) by decreasing the Transverse Latency Time (TLT) and increasing the Step Down Latency (SDL), respectively in dose dependent manner. "
|2.||Rheumatic Diseases (Rheumatism)
|4.||Immune System Diseases (Immune Disorders)
12/16/2002 - "The idea of treating auto immune diseases which are resistant to conventional immunodepressive treatment by autologous transplantation of haematopoietic stem cells obtained from peripheral blood (TAPH) is based on the hypothesis that immuno ablative treatment would destroy the patients anti self lymphocytes and the reinfusion of stem cells would give rise to lymphocytes which would be tolerant of the antigens responsible for the auto immune response. "
01/01/2008 - "Review of the literature shows that TAPH may develop in conditions of increased water absorption due to an increased sweat quantity, such as hyperhidrosis, or an increased sweat electrolyte concentration, such as CF. "
01/01/2008 - "We report on a 10-year-old boy with type I diabetes, who developed the typical symptoms of TAPH concomitantly with the onset of palmar hyperhidrosis. "
|3.||Ethanol (Ethyl Alcohol)
|2.||Transplantation (Transplant Recipients)